CYT387 Articles
Gilead agrees to buy YM BioSciences for $510 million
13 December 2012
YM BioSciences - to partner or not to partner?
13 November 2012
Showing 1-3 of 3 articles
- 1
- Bristol-Myers' data on Yervoy and nivolumab causes a stir
- Boehringer Ingelheim transitions to propellant-free Combivent Respimat; names new BMD member
- Encouraging results with Sangamo's SB-728-T in HIV treatment
- Sanofi prepares for regulatory filing of MF candidate on positive JAKARTA study results
- New study shows UCB's Neupro reduces NSBP in RLS patient
